Clinical Pediatric Dermatology Open Access

  • ISSN: 2472-0143
  • Journal h-index: 3
  • Journal CiteScore: 0.24
  • Journal Impact Factor: 0.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Perspective - (2023) Volume 9, Issue 1

The Numerous Benefits of Varicella Vaccination in Pediatrics
Takao Ozaki*
 
Department of Pediatrics, University of Hamamatsu, Japan
 
*Correspondence: Takao Ozaki, Department of Pediatrics, University of Hamamatsu, Japan, Email:

Received: 01-Mar-2023, Manuscript No. IPCPDR-23-16501; Editor assigned: 03-Mar-2023, Pre QC No. IPCPDR-23-16501 (PQ); Reviewed: 17-Mar-2023, QC No. IPCPDR-23-16501; Revised: 22-Mar-2023, Manuscript No. IPCPDR-23-16501 (R); Published: 29-Mar-2023, DOI: 10.36648/2472-0143.9.1.09

Introduction

Varicella, commonly known as chickenpox, is a highly contagious viral infection that primarily affects children. While it is often considered a mild childhood illness, it can lead to severe complications, especially in vulnerable populations. Thankfully, medical advancements have brought about the introduction of the Varicella vaccine, significantly reducing the burden of this disease. In this article, we will explore the benefits of Varicella vaccination in pediatrics, highlighting its role in preventing the spread of the disease, reducing complications, and protecting vulnerable populations. Varicella vaccination has proven to be highly effective in preventing the occurrence of chickenpox.

Description

The vaccine contains a weakened form of the Varicella-Zoster virus, which triggers an immune response in the body without causing illness. By introducing the attenuated virus, the vaccine stimulates the production of antibodies that protect against future Varicella infections. Vaccinated individuals are less likely to contract chickenpox, reducing its transmission within communities. One of the significant advantages of Varicella vaccination is its ability to reduce the severity of chickenpox symptoms. Vaccinated individuals who do contract the virus often experience milder cases with fewer lesions and a shorter duration of illness. By preventing severe forms of chickenpox, the vaccine decreases the risk of complications associated with the disease. Chickenpox complications can be particularly problematic in children, especially those with compromised immune systems or underlying health conditions. Varicella can lead to bacterial skin infections, pneumonia, encephalitis, and other serious complications. Vaccination significantly reduces the incidence of these complications, protecting vulnerable populations and reducing the strain on healthcare systems. Varicella vaccination plays a crucial role in establishing herd immunity. Herd immunity occurs when a significant portion of the population is immunized, creating a protective shield against the spread of infectious diseases. Vaccinated individuals act as barriers, preventing the transmission of the virus to others, including those who are unable to receive the vaccine due to medical reasons. By achieving high vaccination rates, communities can shield infants who are too young to be vaccinated, individuals with weakened immune systems, pregnant women, and individuals with contraindications to the vaccine. This approach ensures the overall well-being of the population and reduces the likelihood of outbreaks. Prior to the introduction of the Varicella vaccine, chickenpox was a leading cause of hospitalizations in children. Severe cases often required medical intervention, resulting in increased healthcare costs and burden on healthcare facilities. With widespread vaccination, the incidence of hospitalizations due to Varicella has significantly decreased. Studies have shown that countries with routine Varicella vaccination programs have experienced a substantial decline in hospital admissions related to chickenpox. This reduction in hospitalizations not only benefits the affected children but also alleviates the strain on healthcare resources and reduces healthcare costs associated with Varicella treatment.

Conclusion

The benefits of Varicella vaccination extend beyond the immediate prevention of chickenpox. By reducing the incidence of Varicella in the population, the vaccine also decreases the risk of shingles, a painful viral infection caused by the reactivation of the Varicella- Zoster virus later in life. Varicella vaccination has been shown to decrease the likelihood of developing shingles by boosting immunity against the virus. This long-term benefit helps protect individuals from the debilitating pain and complications associated with shingles, which can persist for months or even years.

Citation: Ozaki T (2023) The Numerous Benefits of Varicella Vaccination in Pediatric. Clin Pediatr Dermatol. 9:09.

Copyright: © 2023 Ozaki T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.